Related Experiment Video
Updated: Feb 27, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer
Amaia Zabala-Letona1,2, Amaia Arruabarrena-Aristorena1, Natalia Martín-Martín1,2
1CIC bioGUNE, Bizkaia Technology Park, 801 building, 48160, Derio, Spain.
Abstract:
Activation of the PTEN-PI3K-mTORC1 pathway consolidates metabolic programs that sustain cancer cell growth and proliferation. Here we show that mechanistic target of rapamycin complex 1 (mTORC1) regulates polyamine dynamics, a metabolic route that is essential for oncogenicity. By using integrative metabolomics in a mouse model and human biopsies of prostate cancer, we identify alterations in tumours affecting the production of decarboxylated S-adenosylmethionine (dcSAM) and polyamine synthesis. Mechanistically, this metabolic rewiring stems from mTORC1-dependent regulation of S-adenosylmethionine decarboxylase 1 (AMD1) stability. This novel molecular regulation is validated in mouse and human cancer specimens. AMD1 is upregulated in human prostate cancer with activated mTORC1. Conversely, samples from a clinical trial with the mTORC1 inhibitor everolimus exhibit a predominant decrease in AMD1 immunoreactivity that is associated with a decrease in proliferation, in line with the requirement of dcSAM production for oncogenicity. These findings provide fundamental information about the complex regulatory landscape controlled by mTORC1 to integrate and translate growth signals into an oncogenic metabolic program.
Insights
The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates polyamine metabolism, crucial for cancer growth. This study reveals mTORC1 controls S-adenosylmethionine decarboxylase 1 (AMD1) stability, impacting cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Metabolic Pathways
Background:
- The PTEN-PI3K-mTORC1 pathway is critical for cancer cell growth and proliferation.
- Polyamines are essential metabolites that support oncogenicity.
Purpose of the Study:
- To investigate the role of mTORC1 in regulating polyamine metabolism in prostate cancer.
- To identify specific molecular mechanisms linking mTORC1 to polyamine synthesis alterations.
Main Methods:
- Integrative metabolomics analysis in a mouse model of prostate cancer.
- Analysis of human prostate cancer biopsies.
- Assessment of S-adenosylmethionine decarboxylase 1 (AMD1) stability and immunoreactivity.
- Evaluation of samples from a clinical trial of an mTORC1 inhibitor.
Main Results:
- mTORC1 regulates polyamine dynamics by controlling the stability of S-adenosylmethionine decarboxylase 1 (AMD1).
- Tumors exhibit altered production of decarboxylated S-adenosylmethionine (dcSAM) and polyamine synthesis.
- AMD1 is upregulated in human prostate cancer with activated mTORC1.
- Treatment with an mTORC1 inhibitor (everolimus) decreased AMD1 levels and proliferation.
Conclusions:
- mTORC1 integrates growth signals to promote an oncogenic metabolic program through polyamine regulation.
- AMD1 stability is a novel regulatory point controlled by mTORC1, essential for dcSAM production and cancer cell growth.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
PI3K/mTOR/AKT Signaling Pathway
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Biosynthesis of Nucleic Acids

